Beodeul Kang
机构：CHA University Bundang Medical Center, CHA University · ORCID：0000-0001-5177-8937
发表论文 163 篇 · 总被引 2665 次 · h-index 30
代表论文
- Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline) (2025 · Journal of the Korean Gastric Cancer Association · 被引 112)
- Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer (2024 · Journal of Hepatology · 被引 51)
- Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus Bevacizumab (2025 · Liver Cancer · 被引 17)
- Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries (2024 · Liver Cancer · 被引 14)
- Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study (2025 · JHEP Reports · 被引 12)
- Distinct Characteristics and Changes in Liver Function of Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab for More Than 1 Year (2024 · Cancer Research and Treatment · 被引 8)